MAINTENANCE RITUXIMAB IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL IN MANTLE CELL LYMPHOMA PATIENTS RESPONDING TO INDUCTION THERAPY WITH BENDAMUSTINE + RITUXIMAB (BR).

Authors :: Hill, B.T.
Switchenko, J.M.
Martin, P.
Churnetski, M.C.
Sawalha, Y.
Goyal, S.
Shanmugasundaram, K.
Calzada, O.
Kolla, B.
Bachanova, V.
Gerson, J.N.
Barta, S.K.
Maldonado, E.
Gordon, M.
Danilov, A.
Grover, N.S.
Mathews, S.
Burkart, M.
Karmali, R.
Ghosh, N.
Source :: Hematological Oncology; Jun2019 Supplement S1, Vol. 37, p405-407, 3p
Publication Year :: 2019

Full Text Access

Tools